14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:TCDA
Delisted

Tricida Inc Stock Company Profile

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.108
+0 (+0%)
At Close: Apr 21, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Information

7000 Shoreline Court, Suite 201

South San Francisco CA 94080

415 429 7800

www.tricida.com

Industry: Biotechnology

Sector: Healthcare

Tricida Inc

Description

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Click to get the best stock tips daily for free!

About Tricida Inc

Tricida Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.... TCDA Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT